JP2012514020A5 - - Google Patents

Download PDF

Info

Publication number
JP2012514020A5
JP2012514020A5 JP2011544017A JP2011544017A JP2012514020A5 JP 2012514020 A5 JP2012514020 A5 JP 2012514020A5 JP 2011544017 A JP2011544017 A JP 2011544017A JP 2011544017 A JP2011544017 A JP 2011544017A JP 2012514020 A5 JP2012514020 A5 JP 2012514020A5
Authority
JP
Japan
Prior art keywords
phenyl
quinazolin
ylamino
chloro
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011544017A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012514020A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/067494 external-priority patent/WO2010076238A1/en
Publication of JP2012514020A publication Critical patent/JP2012514020A/ja
Publication of JP2012514020A5 publication Critical patent/JP2012514020A5/ja
Pending legal-status Critical Current

Links

JP2011544017A 2008-12-29 2009-12-18 置換キナゾリン化合物 Pending JP2012514020A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08360043.7 2008-12-29
EP08360043 2008-12-29
PCT/EP2009/067494 WO2010076238A1 (en) 2008-12-29 2009-12-18 Substituted quinazoline compounds

Publications (2)

Publication Number Publication Date
JP2012514020A JP2012514020A (ja) 2012-06-21
JP2012514020A5 true JP2012514020A5 (enExample) 2013-03-28

Family

ID=41735344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011544017A Pending JP2012514020A (ja) 2008-12-29 2009-12-18 置換キナゾリン化合物

Country Status (23)

Country Link
US (1) US8389530B2 (enExample)
EP (1) EP2381943A1 (enExample)
JP (1) JP2012514020A (enExample)
KR (1) KR20110120878A (enExample)
CN (1) CN102333533A (enExample)
AU (1) AU2009334869A1 (enExample)
BR (1) BRPI0924067A2 (enExample)
CA (1) CA2748319A1 (enExample)
CO (1) CO6390105A2 (enExample)
CR (1) CR20110368A (enExample)
DO (1) DOP2011000209A (enExample)
EA (1) EA019110B1 (enExample)
EC (1) ECSP11011204A (enExample)
IL (1) IL213742A0 (enExample)
MA (1) MA32968B1 (enExample)
MX (1) MX2011007064A (enExample)
NI (1) NI201100134A (enExample)
NZ (1) NZ593949A (enExample)
PE (1) PE20120424A1 (enExample)
SG (1) SG172415A1 (enExample)
TN (1) TN2011000319A1 (enExample)
WO (1) WO2010076238A1 (enExample)
ZA (1) ZA201104777B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201204723A (en) 2010-06-22 2012-02-01 Fovea Pharmaceuticals Heterocyclic compounds, their preparation and their therapeutic application
BR112015000653A2 (pt) 2012-07-11 2019-11-05 Blueprint Medicines Corp compostos inibidores do receptor de fator de crescimento de fibroblasto, sua composição farmacêutica e seus usos
DK3395814T3 (da) 2013-10-25 2022-07-04 Blueprint Medicines Corp Hæmmere af fibroblastvækstfaktorreceptoren
WO2015108992A1 (en) 2014-01-15 2015-07-23 Blueprint Medicines Corporation Heterobicyclic compounds and their use as fgfr4 receptor inhibitors
KR101715448B1 (ko) * 2014-07-16 2017-03-20 주식회사 큐리언트 염증성 질환 치료용 화합물
JP6385584B2 (ja) 2014-12-24 2018-09-05 ギリアード サイエンシーズ, インコーポレイテッド Hivの処置のための縮合ピリミジン化合物
TWI770552B (zh) 2014-12-24 2022-07-11 美商基利科學股份有限公司 喹唑啉化合物
PT3237397T (pt) 2014-12-24 2019-02-08 Gilead Sciences Inc Compostos de isoquinolina para o tratamento de hiv
CN112239459B (zh) * 2019-07-19 2021-11-26 中国科学院上海药物研究所 稠环嘧啶氨基化合物、其制备方法、药物组合物及应用
CN115916759B (zh) * 2020-06-19 2025-07-15 泰州红云制药有限公司 取代喹唑啉类化合物、其制备方法、药物组合及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0015718A (pt) * 1999-11-22 2002-07-23 Warner Lambert Co Quinazolinas e seu uso para inibição de enzimas de cinase dependente de ciclina
MXPA05007503A (es) 2003-01-17 2005-09-21 Warner Lambert Co Heterociclicos 2-aminopiridina sustituidos como inhibidores de proliferacion celular.
CA2542329A1 (en) 2003-10-16 2005-04-28 Chiron Corporation 2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
EP2543376A1 (en) 2004-04-08 2013-01-09 Targegen, Inc. Benzotriazine inhibitors of kinases
PL382308A1 (pl) 2004-08-25 2007-08-20 Targegen, Inc. Związki heterocykliczne i sposoby stosowania
US20070054916A1 (en) * 2004-10-01 2007-03-08 Amgen Inc. Aryl nitrogen-containing bicyclic compounds and methods of use
MX2007011500A (es) 2005-03-16 2007-11-21 Targegen Inc Compuestos pirimidina y metodos de uso.
EP1878727A4 (en) * 2005-04-28 2013-11-13 Kyowa Hakko Kirin Co Ltd 2-AMINOQUINAZOLINE DERIVATIVES
JP2008543775A (ja) 2005-06-08 2008-12-04 ターゲジェン インコーポレーティッド 眼の障害を治療するための方法および組成物
TW200808739A (en) * 2006-04-06 2008-02-16 Novartis Vaccines & Diagnostic Quinazolines for PDK1 inhibition
CA2673003A1 (en) * 2006-12-22 2008-07-03 Novartis Ag Quinazolines for pdk1 inhibition

Similar Documents

Publication Publication Date Title
JP2012514020A5 (enExample)
JP2009535362A5 (enExample)
CA2748319A1 (en) Substituted quinazoline compounds of general formula (i) and uses thereof for treating disorders relating to tyrosine kinase dysregulation
JP2009534398A5 (enExample)
JP2009534471A5 (enExample)
JP2012525332A5 (enExample)
JP2012510502A5 (enExample)
TW434227B (en) Novel N-benzylindole and benzopyrazole derivatives with anti-asthmatic, anti-allergic, anti-inflammatory and immune modulating effect
BRPI0906495B1 (pt) compostos derivados de indolil-piridona e composição farmacêutica
JP2008513500A5 (enExample)
JP2008536825A5 (enExample)
JP2009535356A5 (enExample)
JP2006522771A5 (enExample)
JP2006500348A5 (enExample)
JP2007524696A5 (enExample)
JP2007509985A5 (enExample)
JP2005509624A5 (enExample)
JP2010521451A5 (enExample)
JP2008538750A5 (enExample)
JP2005539000A (ja) Alk5阻害剤としての2−フェニルピリジン−4−イル誘導体
ATE509935T1 (de) Mischungen aus mono-carboxylfunktionalisierten dialkylphosphinsäuren, ein verfahren zu ihrer herstellung und ihre verwendung
JP2005529954A5 (enExample)
CA2628233A1 (en) 5-lipoxygenase-activating protein (flap) inhibitors
CA2463989A1 (en) Pyrimidine derivatives, pharmaceutical compositions containing these compounds, the use thereof and process for the preparation thereof
JP2011510929A5 (enExample)